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Abstract
Background: The inherent ability of ventricular myocardium to increase its force of contraction
in response to an increase in contraction frequency is known as the cardiac force-frequency
relation (FFR). This relation can be easily obtained in the stress echo lab, where the force is
computed as the systolic pressure/end-systolic volume index ratio, and measured for increasing
heart rates during stress. Ideally, the noninvasive, imaging independent, objective assessment of FFR
would greatly enhance its practical appeal.
Objectives: 1 – To evaluate the feasibility of the cardiac force measurement by a precordial
cutaneous sensor. 2 – To build the curve of force variation as a function of the heart rate. 3 – To
compare the standard stress echo results vs. this sensor operator-independent built FFR.
Methods:  The transcutaneous force sensor was positioned in the precordial region in 88
consecutive patients referred for exercise, dipyridamole, or pacing stress. The force was measured
as the myocardial vibrations amplitude in the isovolumic contraction period. FFR was computed as
the curve of force variation as a function of heart rate. Standard echocardiographic FFR
measurements were performed.
Results: A consistent FFR was obtained in all patients. Both the sensor built and the echo built FFR
identifiy pts with normal or abnormal contractile reserve. The best cut-off value of the sensor built
FFR was 15.5 g * 10-3 (Sensitivity = 0.85, Specificity = 0.77). Sensor built FFR slope and shape mirror
pressure/volume relation during stress. This approach is extendable to daily physiological exercise
and could be potentially attractive in home monitoring systems.
Introduction
The frequency-dependent control of transmembrane Ca2+
entry via voltage-gated Ca2+ channels provides cardiac
cells with a highly sophisticated short-term system for the
regulation of intracellular Ca2+  homeostasis [1]. An
increased stimulation rate increases the force of contrac-
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tion: the explanation is repetitive Ca2+ entry with each
depolarization and, hence, an accumulation of cytosolic
calcium. This inherent ability of ventricular myocardium
to increase its force of contraction in response to an
increase in contraction frequency is known as the cardiac
force-frequency relation (FFR) [2]. Its assessment is still
elusive for the clinical cardiologist, although several inva-
sive and non-invasive methods have been proposed [3-6].
Among these methods, one exploits standard 2-D stress
echocardiography and another heart vibrations changes
detectable by an accelerometer, i.e. a device measuring
mechanical vibrations generating heart sounds [7,8].
Echocardiography uses artificially generated cardiac
reflections; the accelerometer simply records naturally
generated heart vibrations. With echocardiography the
force is computed as the systolic pressure (SP)/end-systo-
lic volume index (ESV) ratio [9-13]. It is important to eval-
uate not only the variation of force between rest and peak
stress test, but also how the force varies with the increase
of frequency. In fact, it is known that the FFR can be nor-
mal up-sloping or abnormal flat or biphasic, that is with
an initial up-sloping followed by a later down-sloping
trend [6,14] (Figure 1).
FFR, from myocardial strips to the echo lab Figure 1
FFR, from myocardial strips to the echo lab. Time sequence during stress echo (upper panel). The force-frequency relation is built off line. The 
force-frequency relationship is defined up-sloping when the peak exercise SP/ESV index is higher than baseline and intermediate stress values; biphasic, 
with an initial up-sloping followed by a later down-sloping trend, when the peak exercise systolic pressure/end-systolic volume index is lower than interme-
diate stress values; flat or negative, when the peak exercise systolic pressure/end-systolic volume index is equal to or lower than baseline stress values. The 
critical heart rate (or optimum stimulation frequency) is defined as the heart rate at which systolic pressure/end-systolic volume index reaches the maxi-
mum value during progressive increase in heart rate; in biphasic pattern, the critical heart rate is the heart rate beyond which the systolic pressure/end-
systolic volume index has declined by 5%; in negative pattern the critical heart rate is the starting heart rate. The critical heart rate (or optimum stimulation 
frequency) is the human counterpart of the treppe phenomenon in isolated myocardial strips; the optimal heart rate is not only the rate that would give 
maximal mechanical performance of an isolated muscle twitch, but also is determined by the need for diastolic filling. Lower panel. Plots of average steady-
state isometric twitch tension versus stimulation frequency in non-failing and failing myocardium. Measurements of twitch tension in isolated left-ventricu-
lar strips from explanted cardiomyopathic hearts compared with non-failing hearts show reduction in peak rates of generation and relaxation of twitch ten-
sion and a decrease in slope of tension rate vs. contraction frequency. The FFR of these failing groups both exhibit a negative treppe at contraction 
frequencies above about 100 bpm. The contraction frequency at which the FFR begins its descending limb ("optimum stimulation frequency") declines pro-
gressively in the order: ASD (atrial septal defect), CAD (coronary artery disease), IDDM (diabetic myopathy), MR (mitral regurgitation), and DCM (dilated 
cardiomyopathy). (Modified from: Mulieri AL. In "Heart Metabolism in Failure" R.A. Howarth Ed. 1997. The role of myocardial force-frequency relation in 
left ventricular function and progression of human heart failure).Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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Despite the advantages of a completely noninvasive
approach, the technique enables therapy effectiveness and
clinical status to be verified other than by time distance
checks. Since FFR slope and shape are key determinants of
clinical outcome in diseased hearts, [11-13,15] FFR
should be monitored with noninvasive operator-inde-
pendent methods (Figure 2, 3, 4).
Aims of this study are: 1 – To evaluate the feasibility of the
cardiac force measurement by a precordial cutaneous sen-
sor 2 – To build the curve of force variation as a function
of the heart rate during exercise, dipyridamole and pacing
stress echocardiography. 3 – To compare the standard
echocardiographic force-frequency relation measure-
ments and hemodynamic assessment vs. this new sensor
operator-independent built force-frequency relation.
Methods
Patient selection
We enrolled 88 consecutive patients (56 males, 62 ± 13
years) referred for stress echocardiography (49 for exer-
cise, 31 for dipyridamole, 8 for pacing stress). The type of
stress was clinically driven for exercise vs. dipyridamole,
and by the presence of a permanent pace maker for pacing
stress. The characteristics of the study patients are reported
in Table 1. The local Ethical Committee approved the
study protocol. All the patients gave their written
informed consent before entering the study.
All patients met the following inclusion criteria: 1)
referred to stress echo for clinically-driven testing; 2)
acoustic window of acceptable quality; 3) willingness to
enter the study. Exclusion criteria were: 1) unstable angina
The isovolumic contraction force sensor for FFR building Figure 2
The isovolumic contraction force sensor for FFR building. The transcutaneous force sensor is based on a linear accelerometer. The device 
includes in one single package a MEMS sensor that measures a capacitance variation in response to movement or inclination and a factory trimmed inter-
face chip that converts the capacitance variations into analog signal proportional to the motion. The device has a full scale of ±2·g (g = 9.8 m/s2) with a res-
olution of 0.0005·g. The acceleration signal is converted to digital and recorded by a laptop PC, together with an ECG signal. The system is also provided 
with a user interface that shows both the acceleration and the ECG signals while the acquisition is in progress. A QRS detection algorithm is used to auto-
matically locate the beginning of the isovolumic ventricular contractions and to record isovolumic contraction force vibrations (which audible components 
give rise to the first heart sound). All the parameters are acquired as instantaneous values at baseline and during stress; mobile mean is utilized to assess 
baseline value (1 minute recording), at each incremental stress test, at peak test, and during recovery.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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or recent myocardial infarction; 2) moderate-to-severe
aortic stenosis; 3) hemodynamic instability, documenta-
tion of life-threatening ventricular arrhythmias (sustained
ventricular tachycardia or ventricular fibrillation), atrial
fibrillation. From the initially considered population of
92 patients, 4 were excluded for poor acoustic window (n
= 2), or refusal to give written informed consent (n = 2).
Semi-supine bicycle exercise
Graded bicycle semi-supine exercise echo was performed
in 49 patients starting at an initial workload of 25 watts
lasting for 2 minutes; thereafter the workload was
increased stepwise by 25 watts at 2 minutes interval. A 12-
lead electrocardiogram and blood pressure determination
The curve of the systolic isovolumic contraction force variation as a function of heart rate is finally computed Figure 4
The curve of the systolic isovolumic contraction force variation as a function of heart rate is finally computed. All the parameters are acquired as instanta-
neous values at baseline and during stress; mobile mean is utilized to assess baseline value (1 minute recording), at each incremental stress test, at peak 
test, and during recovery. The data can be also read remotely by a telemetric connection. Left panel: instantaneous force values scattering (red points) 
depend on the respiratory cycle and thorax expansion; blue curve = force mobile mean. Right panel: blue curve = exercise in progress; red curve = recov-
ery.
Left panel: the force-frequency relation builder device Figure 3
Left panel: the force-frequency relation builder device. Right panel: force-frequency recording during bycicle semi-supine stress echo. The transcutaneous 
force sensor was housed in a small case which is positioned in the mid-sternal precordial region and is fastened by a solid gel ECG electrode. The acceler-
ation signal is converted to digital and recorded by a laptop PC, together with an ECG signal. The system is also provided with a user interface that shows 
both the acceleration and the ECG signals while the acquisition is in progress. The system is portable, and the remote transmission is feasible and simple.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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were performed at baseline and every minute thereafter
[16].
Dipyridamole stress echo
Dipyridamole stress echo was performed following the
protocol of American Society of Echocardiography
[16,17], using Dipyridamole 0.84 mg/kg in 6' (accelerated
protocol) in 31 patients.
Contraindications of using dipyridamole were asthma,
hypotension, bradyarrhythmias.
Pacing stress echo
The study population consisted of 8 patients with a per-
manent pace maker. The pacing protocol was accelerated
(with a 10-beat increment every 60 s) until one of the fol-
lowing criteria was reached: 1 – 85% of maximal heart rate
(age-corrected: 220 – age for men, 200 – age for women);
or 2 – PM maximal programmable heart rate (which var-
ied widely, according to the model of PM, up to 170 bpm
during stress). Stimulation was performed, wherever pos-
sible, in atrial stimulation mode, or dual-chamber (DDD)
pacing to have normal contraction sequence. In the VVI-
implanted patients, ventricular stimulation mode was
used [10].
Diagnostic end points and interruption criteria
The diagnostic end-points for all types of stress were: the
development of obvious echocardiography positivity,
obvious alterations of ECG (ST segment shift >3 mm). The
exam was also stopped in case of limiting subjective side
effects or hypertension (systolic pressure >220 mmHg,
diastolic pressure >120 mmHg), hypotension (relative or
absolute) with decrease of the blood pressure >30 mmHg,
supraventricular arrhythmias (supraventricular tachycar-
dia, atrial fibrillation), ventricular arrhythmias (ventricu-
lar tachycardia, frequent and polymorphous ventricular
beats); limiting dyspnoea, or maximal predicted heart rate
in the absence of ischemia [16].
Data acquisition
All patients underwent transthoracic echocardiography at
baseline and during stress.
Left ventricular end-diastolic and end-systolic volumes
were measured from apical four- and two-chamber view,
by an experienced observer using the biplane Simpson-
method [18]. Only representative cycles with optimal
endocardial visualization were measured and the average
of three measurements was taken. The endocardial border
was traced, excluding the papillary muscles. The frame
captured at the R wave of the ECG was considered to be
the end-diastolic frame, and the frame with the smallest
left ventricular cavity the end systolic frame. Images were
acquired at baseline and at each increase in heart rate of
10 beats during stress.
Regional wall motion analysis
The Wall Motion Score Index (WMSI) was calculated in
each patient at baseline and peak stress, according to the
recommendations of the American Society of Echocardi-
ography from 1 = normal-hyperkinetic to 4 = dyskinetic in
a 17 segment model of the left ventricle [16,19].
Blood pressure analysis
One nurse recorded blood pressures at rest and during
each individual study. The blood pressure recording was
made using a sphygmomanometer and the diaphragm of
a standard stethoscope. Systolic and diastolic blood pres-
sure was obtained in the right arm. During exercise test,
blood pressure recording was obtained with patient lying
in a left rotated semi supine position and instructed to
hand grip to the left support with their left hand. Patients
have been told to let their right hand go limp when blood
pressure was measured.
End-systolic pressure-volume determination
In order to build the force-frequency relation, the force
was determined at each step as the ratio of the systolic
pressure (cuff sphygmomanometer)/end-systolic volume
index (biplane Simpson rule/body surface area). At each
heart rate step three cardiac cycles were analyzed and the
ESV was calculated as the mean value. The FFR was built
off line. The slope of the relationship was calculated as the
SP/ESV (Systolic Pressure/End-Systolic Volume) index
increase (Δ SP/ESV index from baseline to peak stress)
(Figure 1 and Figure 5). The FFR was defined up-sloping
when peak exercise SP/ESV index was higher than baseline
and intermediate stress values; biphasic, with an initial
up-sloping followed by a later down-sloping trend, when
peak exercise systolic pressure/end-systolic volume index
was lower than intermediate stress values [9-13]; flat or
Table 1: Characteristics of the study patients
EXERCISE DIP PACING
PT n° 49 31 8
Age (years) 58 ± 13 66 ± 11 71 ± 10
Males 33 17 6
Controls 9 0 0
Previous PTCA/By pass 15 15 2
Previous myocardial infarction 12 8 2
Arterial hypertension 27 17 5
Atypical chest pain/miscellaneous 13 10 4
BB on 21 17 5
ACEi on 11 10 5
Ca CB on 11 8 1
ACEi = angiotensin converting enzyme inhibitors; BB = beta blockers; 
Ca CB = calcium channel blockersCardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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negative, when peak exercise systolic pressure/end-systolic
volume index was equal to or lower than baseline stress
values.
Arterial elastance and ventricular-arterial coupling
In all, ventricular arterial coupling was indexed by the
ratio of left ventricular systolic elastance index (systolic
pressure/end-systolic volume index) to arterial elastance
(Ea, ratio of end-systolic pressure by stroke volume).
Echocardiography (for ESV and stroke volume) and cuff
sphygmomanometer (systolic pressure, multiplied x 0.90
to obtain end-systolic pressure) provided the raw meas-
urements.
Because stroke volume (and input impedance) varies
directly with body size, arterial elastance was adjusted for
body surface area (EaI) to better reflect differences in arte-
rial properties with age and between the genders adjusted
for differences in body size [20,21]. Of note ventricular-
arterial coupling is ventricular elastance/arterial elastance,
which can further be described as: end-systolic pressure/
end-systolic LV volume divided by end-systolic pressure/
stroke volume: the pressure terms in the numerator and
the denominator cancel out, and ventricular-arterial cou-
pling equals to stroke volume/end-systolic volume.
Systemic Vascular Resistance (SVR)
SVR were calculated according to the traditional formula:
SVR = 80 * (MAP-5)/CO,
where 5 is an approximation of the right atrial pressure
and MAP is mean arterial pressure.
Systemic arterial compliance
Systemic arterial compliance (C) was calculated as stroke
volume index/systemic arterial pulse pressure; where
pulse pressure = systolic blood pressure - diastolic blood
pressure [22].
The cardiac force measurement by the precordial 
cutaneous sensor and the operator-independent force-
frequency relation
Isovolumic myocardium contractions generate vibrations
which have audible components that are responsible for
the first heart sound [7,8]. These vibrations can be meas-
ured with modern accelerometer based technology. These
devices are small in size and can be easily used to build a
cutaneous sensor (Figure 2).
The transcutaneous force sensor is based on a linear accel-
erometer from STMicroelectronics (LIS3). The device
includes in one single package a MEMS sensor that meas-
Force-Frequency relation during exercise in a normal subject wherein the memorized parameters are the heart rate, the ven- tricular contractile force, and the curve of force variation as a function of heart rate Figure 5
Force-Frequency relation during exercise in a normal subject wherein the memorized parameters are the heart rate, the ventricular contractile force, and 
the curve of force variation as a function of heart rate. Left panels: the force data is derived from the precordial cardiac sensor (maximum vibrations ampli-
tude in the first 150 ms following the R wave). Right panels: the force data is derived from the ventricular force computed as SP/ESVi, which indicates the 
left ventricular end-systolic pressure volume ratio (end-systolic ventricular pressure divided by the end-systolic volume). Simultaneous recording is feasi-
ble, totally non-invasive. Echocardiography uses artificially generated cardiac reflections; the isovolumic systolic operator-independent force sensor simply 
records naturally generated heart vibrations.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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ures a capacitance variation in response to movement or
inclination and a factory trimmed interface chip that con-
verts the capacitance variations into analog signal propor-
tional to the motion. The device has a full scale of ±2·g (g
= 9.8 m/s2) with a resolution of 0.0005·g. We housed the
device in a small case (Figure 3) which was positioned in
the mid-sternal precordial region and was fastened by a
solid gel ECG electrode. The acceleration signal was con-
verted to digital and recorded by a laptop PC, together
with an ECG signal. The system is also provided with a
user interface that shows both the acceleration and the
ECG signals while the acquisition is in progress. The data
were analyzed by using software developed in Matlab
(The MathWorks, Inc). A QRS detection algorithm was
used to automatically locate the beginning of the isovolu-
mic ventricular contractions [23]. The amplitude of the
vibration due to isovolumic myocardium contraction was
then obtained to record systolic force for each cardiac beat
[24,25]. While echocardiography uses artificially gener-
ated cardiac reflections, the accelerometer simply records
naturally generated heart vibrations, which audible com-
ponents in the isovolumic (preejection) contraction
period give rise to the first heart sound. Non myocardial
noising vibrations (skeletal muscles, body movements,
breathing) were eliminated by frequency filtering (Figure
4, 5).
The curve of force variation as a function of heart rate was
finally computed as the increment with respect to the rest-
ing force value. All the parameters were acquired as
instantaneous values at baseline and during stress; mobile
mean was utilized to assess baseline value (1 minute
recording), at each incremental stress test, at peak test, and
during recovery. Baseline, peak stress, peak-rest difference
as absolute value, and delta % rest-peak stress values were
computed. The force-frequency relation was defined up-
sloping when the peak stress force was higher than base-
line and intermediate stress values; biphasic, with an ini-
tial up-sloping followed by a later down-sloping trend,
when the peak stress force was lower than intermediate
stress values; flat or negative, when the peak stress force
was equal to or lower than baseline stress values [6,14].
The critical heart rate (or optimum stimulation fre-
quency) was defined as the heart rate at which the force
reaches the maximum value during progressive increase in
heart rate; in biphasic pattern, the critical heart rate is the
heart rate beyond which the force has declined by 5%; in
negative pattern the critical heart rate is the starting heart
rate.
Statistical analysis
SPSS 11 for Windows was utilized for statistical analysis.
The statistical analyses included descriptive statistics (fre-
quency and percentage of categorical variables and mean
and standard deviation of continuous variables). Pearson
chi-square with Fisher's exact test for categorical variables
and the Mann-Whitney test for continuous variables for
inter-group comparisons were performed to confirm sig-
nificance (using Monte Carlo method for small sample
comparisons).
The one-way ANOVA was used to compare continuous
variables between groups; when homogeneity of variance
was not present, the Kruskal-Wallis test for nonparametric
independent samples was used. Intergroup comparison
was performed with Scheffe and Tamhane post hoc tests,
respectively.
Relations between variables were assessed using linear
regression analysis and Pearson's correlation coefficient.
Analysis of variance with Fisher's post hoc pair wise mul-
tiple comparisons was used to assess the significance of
intragroup repeated measures. The best predictors of the
sensor built force-frequency relation slope and shape were
assessed. Receiver operator characteristic (ROC) curve
analysis was used to determine potentially useful thresh-
old values of the sensor built FFR as cut-off for normal vs.
abnormal contractile reserve (as assessed by the standard
echo method: Δ Peak-rest SP/ESV ≥ 4 vs. <4 in exercise,
positive vs. negative FFR in Dipyridamole stress). Contin-
gency tables were constructed to assess the sensitivity and
the specificity of the new operator independent method to
assess the normal threshold for contractile reserve.
Results
Resting and stress echocardiographic findings
Technically adequate images were obtained in all patients
at baseline (by selection) and during stress.
At Peak Exercise
Heart rate was lower in the dipyridamole than in the exer-
cise and pacing groups. The mean ejection fraction
increased in the exercise and Dip groups, while decreased
in the pacing group. Regional wall motion abnormalities
occurred in 4 patients of the exercise, 1 patient of Dip and
2 patients of the pacing groups (Table 2).
Contractile response to stress
SP/ESV index increased to 14.7 ± 8 mmHg/mL/m2 in the
exercise, and in the pacing (to 10.3 ± 8.1 mmHg/mL/m2)
group, although the response was heterogeneous at the
individual level (Table 2). A representation of the behav-
ior of a normal up sloping (Δ SP/ESV index, rest-peak, ≥4
mmHg/mL/m2) an abnormal flat or flat-biphasic (Δ SP/
ESV index, rest-peak, <4 mmHg/mL/m2) force-frequency
relationship is shown in Figure 6 for exercise and in Figure
7 for pacing. An abnormal flat biphasic FFR was present in
13/49 pts of exercise and in 4/8 pts of pacing group.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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The normal FFR cutoff was lower in the dipyridamole
group (normal, Δ SP/ESV index, rest-peak, ≥0 mmHg/mL/
m2; abnormal = Δ SP/ESV index, rest-peak, <0 mmHg/mL/
m2) due to the lower stress heart rate increase and to the
milder catecholamine increase (Figure 8). An abnormal
negative FFR was present in 9/31 pts of the Dip group.
Table 2: Rest and stress data
EXERCISE DIP PM stress
N of pts 49 31 8
Age (yrs) 58 ± 13 § 66 ± 11 71 ± 10
Gender (M/F) 33/16 17/14 6/2
BSA (m2) 1.86 ± .20 1.78 ± .16 1.89 ± .25
Standard echo measurements
LVMI (g/m2) 104 ± 30 104 ± 20 138 ± 35
HR rest (bpm) 72 ± 15 68 ± 12 71 ± 10
HR peak (bpm) 130 ± 21Δ 86 ± 15* 130 ± 12
Δ HR (rest-peak, bpm) 59 ± 20Δ 18 ± 13* 59 ± 14
LV EF % rest 59 ± 10 59 ± 10 51 ± 10
LV EF % peak 65 ± 12‡ 64 ± 11* 49 ± 16
Δ LV EF % (rest-peak) 6 ± 7‡ 5 ± 7 -2 ± 10
WMSI rest 1.08 ± .22 1.11 ± .24 1.21 ± .41
WMSI peak 1.10 ± .26 1.12 ± .24 1.32 ± .44
Δ WMSI (rest-peak) .03 ± .13 .01 ± .06 .11 ± .22
FFR with echocardiography (SP/ESVi)
SP/ESV index rest (mmHg/mL/m2) 7.6 ± 4.6 7.3 ± 2.6 6.3 ± 4.3
SP/ESV index peak (mmHg/mL/m2) 14.7 ± 8.4Δ 8.3 ± 3.5 10.3 ± 8.1
Δ SP/ESV index (rest-peak) 7.1 ± 5.4Δ 1 ± 2.1 3.9 ± 4
Δ SP/ESV index % (rest-peak) 103 ± 74§ 13 ± 26 49 ± 37
Sensor built FFR (isovolumic vibrations)
Force rest (g * 10-3) 10 ± 4.7 12.3 ± 6.1 9.5 ± 4.5
Force peak (g * 10-3) 36 ± 18.7§ 15.3 ± 8.1 15.2 ± 5.6
Δ Force (rest-peak, g * 10-3) 26 ± 16.7§ 3 ± 5 5.7 ± 4.4
Δ Force % (rest-peak) 275 ± 132§ 28 ± 39 74 ± 52
Peripheral pressures, load and coupling
SBP rest (mmHg) 133 ± 24 138 ± 23 141 ± 29
SBP peak (mmHg) 189 ± 26§ 131 ± 27 144 ± 34
Δ SBP % (rest-peak) 45 ± 20§ -5 ± 12 2 ± 12
SVR rest (dyne * sec * cm-5) 2004 ± 740 2076 ± 649 2161 ± 1163
SVR peak (dyne * sec * cm-5) 1472 ± 464 1500 ± 636 1809 ± 737
Arterial compliance rest (mL *m-2/mmHg) 0.51 ± 0.19 0.48 ± 0.15 0.58 ± 0.40
Arterial compliance peak (mL *m-2/mmHg) 0.33 ± 0.12Δ 0.54 ± 0.20* 0.35 ± 0.19
Δ Arterial compliance % (rest-peak) -31 ± 26Δ 18 ± 32* -31 ± 27
Arterial elastance index rest (mmHg/mL/m2) 4.4 ± 1.4 4.4 ± 1.1 4.7 ± 2.7
Arterial elastance index peak (mmHg/mL/m2) 6.2 ± 2Δ 3.9 ± 1.3* 7.3 ± 2.9
Δ Arterial elastance index % (rest-peak) 47 ± 47Δ -10 ± 23* 62 ± 41
Ventricular/arterial coupling rest (SP/ESV/EaI ratio) 1.7 ± .7 1.7 ± .8 1.3 ± .7
Ventricular/arterial coupling peak (SP/ESV/EaI ratio) 2.5 ± 1.3‡ 2.3 ± 1.2 1.3 ± .9
Δ Ventricular/arterial coupling % (rest-peak) 48 ± 65‡ 31 ± 37 -2 ± 40
Cardiac index rest (L/min/m2) 2.1 ± 0.6 2 ± 0.4 2.4 ± 0.8
Cardiac index peak (L/min/m2) 3.9 ± 1.1§ 2.8 ± 0.9 2.7 ± 0.8
Δ Cardiac index % (rest-peak) 99 ± 62§ 37 ± 32 14 ± 22
DBP rest (mmHg) 71 ± 11 71 ± 13 77 ± 11
DBP peak (mmHg) 93 ± 13§ 68 ± 12 80 ± 16
Δ DBP % (rest-peak) 31 ± 20§ -4 ± 13 4 ± 18
LV EDV index rest (mL/m2) 51 ± 16 50 ± 11 65 ± 32
LV EDV index peak (mL/m2) 47 ± 14 50 ± 13 47 ± 30
Δ EDV index % (rest-peak) -7 ± 16‡ -1 ± 12* -30 ± 12
§ = significant differences between exercise and both dipyridamole and pacing stress pts; ‡ = significant differences between exercise and pacing 
stress pts; * = significant differences between dipyridamole and pacing stress pts. Δ = significant differences between exercise and dipyridamole 
stress pts.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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Peripheral pressures, load and coupling
Arterial elastance increased in the exercise and the pacing
groups, while decreased in the dipyridamole, mainly due
to a greater dipyridamole induced arterial compliance
(Table 2).
In the whole group of patients, peak stress diastolic blood
pressure was >80 mmHg in 34 patients, ≤80 mmHg in 54
patients.
Despite similar baseline values, diastolic blood pressure
increased in the exercise, decreased in the dipyridamole,
while unchanged in the pacing group; although the
response was heterogeneous at the individual level (Table
2). An exercise induced diastolic hypertensive response
(DPB ≥ 105 mmHg) was present in 10/49 patients of the
exercise group; 13/31 patients of the Dip group showed a
pharmacological induced hypotensive (DBP <70 mmHg)
response.
Sensor built force-frequency relation
A consistent isovolumic systolic force signal was obtained
in all patients at rest and during stress (Fig. 4, 5). In the
patients as a whole, baseline force amplitude was 10.8 ±
5.3 g * 10-3, increasing to 26.8 ± 18 g * 10-3 at peak stress;
in the group of patients as a whole, the systolic force per-
centage increase from baseline to peak stress was signifi-
cantly related to the percentage increase in heart rate (r =
0.63, p < 0.01).
A typical isovolumic systolic force trend during exercise,
pacing and dipyridamole stress is shown in Figure 6, 7 and
8.
The force increased from 10 ± 4.7 to 36 ± 18.7 g * 10-3 in
the exercise, from 12.3 ± 6.1 to 15.3 ± 8.1 g * 10-3 in the
dipyridamole group, and from 9.5 ± 4.5 to 15.2 ± 5.6 g *
10-3 in the pacing group.
Exercise stress echo Figure 6
Exercise stress echo. Lower panels. The ventricular force is expressed as SP/ESV assessed by echocardiography in the stress echo lab. Left, force-fre-
quency curve with stress echo in a normal subject. An increased heart rate is accompanied by an increased systolic pressure with smaller end-systolic vol-
umes (normal up sloping force-frequency relation). The Δ rest-peak SP/ESV index is >4 mmHg/ml/m2 (normal contractile reserve). Middle, force-frequency 
curve with stress echo in a subject with systemic hypertension with BB therapy on. The force-frequency relation is up sloping with a biphasic pattern at 
higher heart rates. Right, force-frequency curve with stress echo in a subject with coronary artery disease, and stress induced ischemia (abnormal force-
frequency relation). The Δ rest-peak SP/ESV index is = 3, lower than 4 mmHg/ml/m2 (normal cut-off for positive contractile reserve). Upper panels. Sensor 
built force-frequency relation simultaneously recorded in the same patients in which standard echo force-frequency relation was built. Blue curve = exer-
cise in progress; red curve = recovery. Left, normal up sloping force-frequency relation: the Δ rest-peak force is >15.5 g * 10-3 (cut-off value for normal 
contractile reserve). Middle, normal force-frequency relation: (Δ rest-peak force is >15.5 g * 10-3) but less up sloping than the control subject. Right, 
abnormal flat force-frequency relation: the Δ rest-peak force is 5 g * 10-3, much less than 15.5 g * 10-3 (cut-off value for normal contractile reserve).Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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Mean force percentage increase was + 275% in the exercise
patients, + 28% in the dipyridamole patients and +74% in
the eight pacing patients (p < 0.05 between groups) (Table
2).
In the exercise group the Δ rest-peak force was greater in
the 9 control subjects than in the 40 patients (+ 45 ± 19 g
* 10-3 vs. + 22 ± 13 g * 10-3, p < 0.01).
At linear regression analysis best determinants of the force
amplitude changes during stress were the age of patients,
the heart rate, and the contractility SP/ESV index, both as
absolute rest-peak and as rest-peak % changes (Table 3).
Correlations between SP/ESV index changes and force
changes are displayed in Figure 9. At ROC analysis the best
cut-off value of the sensor built systolic force-frequency
relation for normal vs. abnormal contractile reserve at
exercise or pacing stress was Δ isovolumic systolic force =
15.5 g * 10-3  (Sensitivity = 0.85, Specificity = 0.77,
Younden index = 1.62).
The best cut-off value for normal vs. abnormal contractile
reserve at dipyridamole stress was Δ isovolumic systolic
force = 0.35 g * 10-3 (Sensitivity = 0.8, Specificity = 0.71,
Younden index = 1.51).
Discussion
The sensor built force-frequency relation
A stable, reproducible, and consistent isovolumic systolic
force signal was obtained in all patients. This high ampli-
tude vibration is an expression of the tension wave front
Pacing stress Figure 7
Pacing stress. External programming of permanent PM induces a controlled change in heart rate which is independent of the patient capability to exer-
cise. Echocardiographic assessment is highly feasible during PM stress and technically easier than during dynamic exercise. Heart rate increase is achieved 
with no adrenergic stimulation which may inflate the inotropic response through a mechanism different from Bowditch treppe. Lower panels. The ven-
tricular force is expressed as SP/ESV assessed by echocardiography in the stress echo lab. Left, residual contractile reserve; the programmed increase in 
heart rate is accompanied by no changes in systolic pressure with a pronounced decrease of the end-systolic volume (up sloping force-frequency relation). 
The Δ rest-peak SP/ESV index is >2 mmHg/ml/m2 (2 mmHg/ml/m2 = cut-off value for positive vs. negative contractile reserve in pacing stress). Middle, 
force-frequency curve with stress echo in a subject with previous MI and stress induced heterozonal ischemia. The force-frequency relation is biphasic, 
with an initial up-sloping trend followed by a later down-sloping trend at ischemia; an intermediate situation between normal and chronic failing hearts is 
effort induced ischemia, in which the normal up sloping force-frequency relation is abruptly interrupted by the hypoxic dysfunction in calcium homeostasis, 
resulting in reduced contractile performance at ischemia. Right, force-frequency curve with stress echo in a subject with LV dysfunction and dilation (pre-
vious MI). The force-frequency relation is biphasic, with an initial up sloping trend followed by a later down sloping trend. The Δ rest-peak SP/ESV index is 
= 0.1 mmHg/ml/m2 (abnormal contractile reserve). Upper panels. Sensor built force-frequency relation simultaneously recorded in the same patients in 
which standard echo force-frequency relation was built. Left, normal up sloping force-frequency relation: the Δ rest-peak force is >7 g * 10-3 (normal con-
tractile reserve cut-off value for pacing stress). Middle, the same biphasic pattern at ischemia found with stress echo. Right, abnormal biphasic force-fre-
quency relation; the critical heart rate occurs at 110 bpm. The critical heart rate (or optimum stimulation frequency) is the human counterpart of the 
treppe phenomenon in isolated myocardial strips; the optimal heart rate is not only the rate that would give maximal mechanical performance of an iso-
lated muscle twitch, but also is determined by the need for diastolic filling.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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produced during initial activation of the heart in the iso-
volumic contraction phase [23]. Baseline force value had
an ample range (from 4 to 30 g * 10-3). Cardiac vibrations
propagate as mechanical shear waves, and the intervening
viscoelastic thoracic tissue attenuates the higher frequen-
cies and introduces a variable propagation delay [26,27].
The absolute force value in the single patient can be
related to the transthoracic propagation of cardiac vibra-
tions. In fact, when measured epicardially, preejection car-
diac vibrations are up to 10 times more powerful than
when measured on the chest. In our experimental model,
changes of the isovolumic systolic force were linearly
related to the echo SP/ESV index changes. Equally, normal
vs. abnormal echo built FFR was identified by the sensor
built FFR. Attempts have been made by other authors in
animals and in humans to assess the usefulness of myo-
Dipyridamole stress has the well known coronary vasodilator effects mediated by the inhibition of adenosine cellular transport,  eventually leading to extra cellular adenosine accumulation and steal phenomena Figure 8
Dipyridamole stress has the well known coronary vasodilator effects mediated by the inhibition of adenosine cellular transport, eventually leading to extra 
cellular adenosine accumulation and steal phenomena. There is a mild catecholamine release that is responsible for the inotropic effect of the drug: normal 
contractile reserve is present if the force-frequency relation is up sloping instead that abnormal negative. Lower panels. The ventricular force is expressed 
as SP/ESV assessed by echocardiography in the stress echo lab. Left, the mild increase in heart rate at peak stress is accompanied by a mild decrease in 
systolic pressure without decrease of the end-systolic volume. The Δ rest-peak SP/ESV index is <0 mmHg/ml/m2 (negative contractile reserve). Right, the 
mild increase in heart rate is accompanied by a mild decrease in systolic pressure with a more pronounced decrease of the end-systolic volume. The Δ 
rest-peak SP/ESV index is >0 mmHg/ml/m2 (normal contractile reserve). Upper panels. Sensor built force-frequency relation simultaneously recorded in 
the same patients in which standard echo force-frequency relation was built. Left, abnormal negative force-frequency relation: the Δ rest-peak force is less 
than 0.35 g * 10-3 (0.35 g * 10-3 = cut-off value for positive vs. negative contractile reserve in DIP stress). Right, normal contractile reserve: the Δ rest-peak 
force is >0.35 g * 10-3.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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cardial preejection vibration amplitude (which audible
components give rise to the first heart sound) to quantify
left ventricular contractility. Wood et al [28], studied the
regional effects of myocardial ischemia on the epicardially
recorded first heart sound in dogs, demonstrating that the
amplitude of cardiac vibrations in the isovolumic systole
are sensitive to global left ventricular contractility and
independent of the site of application of the sensor (nor-
mal contracting or ischemic non-contracting area).
Sakamoto et al [8] demonstrated that variations of the
first heart sound amplitude are correlated to variations of
the isovolumic maximum rise of LV pressure develop-
ment (max. LV dP/dt).
However, to our knowledge, this is the first work in which
the isovolumic systolic myocardial force vibration was uti-
lized to build the force-frequency relation and in which,
for the first time, a comparison with the echo built FFR
has been made [7]. Since FFR slope and shape are key
determinants of clinical outcome in diseased hearts, [11-
13] FFR should be extensively monitored with this novel
noninvasive operator-independent method. For sake of
clarity, the conceptual and methodological differences
between the FFR and the sound sensor system are con-
trasted in Table 4.
Table 4: FORCE measurement for Force-Frequency Relation 
building
Ultrasound Sound
Diagnostic vibrations artificial spontaneous
Imaging yes no
Wiggers cycle ejection phase isovolumic contraction
LV volumes needed yes no
Systolic pressure needed yes no
Hardware needed 2-D echo accelerometer
Force display off-line on-line
Portability difficult simple
Remote transmission difficult simple
To build the FFR the memorized parameters are the heart rate, the 
ventricular contractile force, and the curve of force variation as a 
function of heart rate. The force data can be derived with ultrasound 
or sound methods.
Table 3: Significant determinants of the sensor built FFR.
Rest Force Peak Force FFR Δ rest-peak FFR Δ % rest-peak
Age (yrs) -0.53 -0.52 -0.43
BSA (m2)
LVMI (g/m2)
LV EF % 0.38 0.27 0.19 0.23
WMSI -0.19
HR (bpm) 0.58 0.63 0.57
SP/ESV index (mmHg/mL/m2) 0.34 0.36 0.49 0.57
Cardiac index (L/min/m2) 0.41 0.45 0.44
Ventricular/arterial coupling 0.38 0.21 0.18 0.22
LV EDV index (mL/m2)
Multiple linear regression analysis to identify significant relationship between predictor variables (first column) and the sensor isovolumic 
contraction force was performed for baseline (second column) and stress values (third, fourth and fifth column). Pearson's correlation coefficients 
are reported in cells with significant (p < 0.05) relationships.
Scatter plots demonstrating relationship between sensor isovolumic con- traction force (y axis) and SP/ESV index ratio (x axis) as delta % rest-peak  values in the whole group of 88 patients Figure 9
Scatter plots demonstrating relationship between sensor isovolumic con-
traction force (y axis) and SP/ESV index ratio (x axis) as delta % rest-peak 
values in the whole group of 88 patients. Green symbols: dipyridamole 
stress; blue symbols: pacing stress; red symbols: exercise stress. Despite 
cardiac vibrations propagate as mechanical shear waves, and the interven-
ing viscoelastic thoracic tissue attenuates the higher frequencies and intro-
duces a variable propagation delay, the sensor recorded force value shows 
good correlation with the standard stress-echo end-systolic elastance 
index (SP/ESV index ratio).Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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FFR and different stress
Exercise evaluates the effect of heart rate increase and ino-
tropic reserve due to adrenergic stimulation during exer-
cise, rather than pure heart rate effect [1,29,30].
The basic property of the force-frequency effect to progres-
sively enhance myocardial contractility as heart rate
increases is augmented at each level of increasing adrener-
gic stimulation as occurs in exercise by catecholamine
spillover. The sensor built FFR fulfilled recording of this
typical pattern, both as absolute values, and for the capa-
bility to distinguish normal vs. abnormal contractile
reserve, as confirmed by the standard echo built FFR cut-
off (Figure 6).
Dipyridamole has the well known coronary vasodilator
effects mediated by the inhibition of adenosine cellular
transport, eventually leading to extra cellular adenosine
accumulation and steal phenomena [17]. There is a mild
catecholamine release that is responsible for the mild ino-
tropic effect of the drug (Figure 8). Simultaneously, the
"pure" heart rate dependent increase in contractility is
blunted due to the low heart rates increase during dipyri-
damole stress. These data are consistent with our findings;
where there was a more pronounced and prolonged
increase in the force signal in the exercise group vs. Dip
group (Table 2). Despite the low number of patients, the
pacing group showed intermediate FFR slope between
exercise and dipyridamole: catecholamine levels are gen-
erally unchanged during the increase in heart rate pro-
duced by pacing [10]. Therefore, at least theoretically,
pacemaker stress echo is more suitable to assess FFR rather
than inotropic reserve.
Clinical implications and current diagnostic options
The assessment of force-frequency relationship is a theo-
retically robust approach for evaluating left ventricular
contractility, which has been deployed clinically using
invasive, complex and technically demanding methods
[3-6]. Previously, we proposed a non-invasive echocardi-
ographic method [9-13] to assess the changes in contrac-
tility during exercise echo. FFR recording is feasible with a
single precordial sensor fastened by a standard solid gel
ECG electrode, in a totally automatic, operator independ-
ent fashion. FFR recording with a non-invasive sensor
offers a new chance to monitor indexes of LV systolic func-
tion, especially in failing hearts and/or exposed to drugs
[31].
In diseased hearts the force-frequency relation is altered.
As the heart fails, there is a change in the gene expression
from the normal adult pattern to that of fetal life with an
inversion of the normal positive slope of the force-fre-
quency relation: systolic calcium release and diastolic cal-
cium reuptake process is lowered at the basal state and,
instead of accelerating for increasing heart rates, slows
down [12]. The force-frequency relation of these diseased
hearts exhibits a flat or negative slope at contraction fre-
quencies above about 100 bpm [14,15] (Figure 10). The
heart rate at which the contractile force begins to decline
diminishes progressively for known pathologies such as
ischemic cardiomyopathy, diabetic cardiomyopathy,
mitral regurgitation and dilated cardiomyopathy. The
Chronic heart failure and sensor built force-frequency relation during exercise Figure 10
Chronic heart failure and sensor built force-frequency relation during exercise. Blue curve: exercise. Red curve: recovery. All patients had 
severely reduced LVEF% and dilated left ventricle. Left and middle panel: the force-frequency relation is biphasic, with an initial up sloping trend followed 
by a down sloping at critical heart rate (left panel, critical heart rate = 90 bpm; middle panel, critical heart rate = 130 bpm). Right panel: the upper rate of 
the paced heart rate is 110 bpm, and the negative down sloping of the biphasic FFR is avoided.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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optimum contraction rate, i.e. the rate corresponding to
the strongest contractile force, varies for each pathology,
for each different stage of the illness, and for each patient
[23]. Different therapies are known to treat chronic heart
failure, however the response must be tailored to each
patient. For example, therapy with beta blockers has
proved effective in cardiomegaly regression and in
improving the myocardial function in patients suffering
from dilated cardiomyopathy, however patients do not
respond uniformly to this therapy. The bradycardic action
of beta blockers reduces the number of daily working
phases of the heart in the negative part of the force-fre-
quency relationship. As the flattening and the descending
limb of the force-frequency curve appears at different fre-
quencies in the different types of cardiac decompensation
and in different patients, the effectiveness of the action of
beta blockers is variable. To optimize chronic heart failure
therapy, it therefore appears essential to identify in each
patient the ascending part of the force-frequency curve
and the specific rate which, when exceeded, initiates the
flattening and the descending part, in order to optimize
individual therapy for chronic heart failure [6]. Monitor-
ing the patient's conditions with this new sensor built FFR
not only enables his condition to be verified in terms of
identifying an abnormal situation not in itself critical but
predictive of a future worsening of chronic heart failure,
but also it enables the effectiveness of therapies and their
influence on the patient's condition under conditions of
normality to be verified [31] (Figure 11). As distribution
of the daily activities of the patient is variable, during the
day the patient experiences, depending on the activities
normally performed, periods in which his force-frequency
relationship is of positive slope and periods in which his
force-frequency relationship is of negative slope or flat.
Known check up systems do not enable therapy effective-
ness to be verified other than by occasional checks on the
patient under rest conditions. By monitoring in accord-
ance with this new sensor, not only can positive or nega-
tive decompensation changes as a result of certain events
be determined, but also the variation in the force-fre-
quency curve over twenty-four hours, days or weeks can
be evaluated. A three-dimensional diagram could be
determined which for each heart rate not only indicates
the instantaneous force value but also enables the varia-
tion of said value with time to be monitored. (Figure 12). 
Telemonitoring in chronic heart failure Figure 11
Telemonitoring in chronic heart failure. In this scenario a patient with DCM has the FFR monitored through the sensor built FFR in baseline condi-
tions (week 1) and during beta-blockade titration (weeks 2 to 9). The force-frequency relation of these diseased hearts exhibits a flat or negative slope at 
contraction frequencies above about 100 bpm. Therapy with beta blockers has proved effective in cardiomegaly regression, however patients do not 
respond uniformly. The bradycardic action of beta blockers reduces the number of daily working phases of the heart in the negative part of the force-fre-
quency relationship. To optimize chronic heart failure therapy, monitoring the patient's FFR enables the effectiveness of therapies to be verified. By moni-
toring in accordance with this new sensor, not only can positive or negative decompensation changes as a result of certain events be determined, but also 
the variation in the force-frequency curve over twenty-four hours, days or weeks. A three-dimensional diagram could be determined which for each heart 
rate not only indicates the instantaneous force value but also enables the variation of said value with time to be monitored.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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If the curve of force variation at a determined heart rate
during the course of the day is reproduced as a two-
dimensional diagram, it gives a continuous indication of
the progress of decompensation situations in response to
the therapies adopted.
Limitations of the study
Heterogeneity of the study population
The patient's number and the incoming disease were dif-
ferent in the exercise, dipyridamole and pacing stress
groups. Controls were present only in the exercise group:
it isn't possible to have physiological and hemodynamic
comparisons between stress groups. However, aim of this
study, was not to assess physiological patterns and differ-
ences between type of stress, that are well known, but sim-
ply assess the feasibility of sensor isovolumic contraction
force recording during stress echocardiography, and to
compare the standard operator-dependent echo vs. this
sensor operator-independent built force-frequency rela-
tion during stress.
Pressure measurements
Because only non-invasive measurements were available,
systolic cuff pressure was used as a surrogate for end-systo-
lic pressure. The non-invasive results tend to overestimate
the actual ratio, in large part because the brachial arterial
pressure reflects an amplified LV pressure wave secondary
to the rheological properties of the arterial tree, and this
difference may lead to overestimation of left ventricular
pressure, specially if younger subjects are studied, in
which blood pressure tends to be overestimated [32].
However, the peak systolic pressure/end systolic volume
ratio is a reproducible method of assessing left ventricular
performance during exercise [33]. Several experimental
studies in animals [34] and in human beings [35] have
shown that use of peak systolic pressure yielded nearly
identical pressure-volume relations.
Telemonitoring in coronary artery disease Figure 12
Telemonitoring in coronary artery disease. An intermediate situation between normal and chronic failing hearts is effort induced ischemia, in which 
the normal up sloping force-frequency relation is abruptly interrupted by the hypoxic dysfunction in calcium homeostasis, resulting in reduced contractile 
performance at ischemia. In this scenario a three-dimensional diagram could be determined in which for each heart rate not only indicates the instantane-
ous force value but also enables the variation of said value with time to be monitored. With patient sleeping (grey FFR curves) range of frequencies of the 
FFR are reduced and the slope of the relation flattened do to the reduced catecholamine spillover. During daily activities, the range of frequencies of the 
FFR are expanded and the slope of the relation steeper. At higher heart rates induced ischemia (red symbols), immediate blunting of the FFR occurs and a 
sudden descending limb begins.Cardiovascular Ultrasound 2007, 5:42 http://www.cardiovascularultrasound.com/content/5/1/42
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Contractility
The estimation of the LV systolic elastance index by SP/
ESV index assumes V0 = 0. The volume axis intercept of the
end-systolic pressure/volume relationship V0 is generally
lower in normal subjects than in CHF patients, and may
also differ among DCM patients. Nevertheless, SP/ESV
index is generally considered as a valid approximation of
LV end systolic elastance [36]. This may not hold true dur-
ing exercise if V0 changes. It has been reported that V0 is
not appreciably altered by inotropic stimulation [37] or
changes in loading conditions: Maughan et al [38]
showed that V0 changed by only 5 mL on average in
response to changes in peripheral vascular resistances of
50 to 200% of normal; Little and Cheng [39] observed no
significant change in V0 during treadmill exercise in dogs.
It is likely, however, that V0 changes during exercise but
this is impossible to assess at such levels of exercise in
man.
Lack of comparisons with invasive measurements of force-
frequency relation
Since end-systolic elastance (Ees), expressing the slope of
the in-vivo, end-systolic ventricular pressure vs chamber
volume relation, is the most "foolproof" window into in
vivo myocardial contractility, Ees should be measured at
each heart rate step increase, as made by Liu and cowork-
ers [3]. But measuring Ees for increasing heart rates is
impractical: increasing heart rates obtained with tempo-
rarily pacing has to be adjunct to the LV conductance cath-
eter, the LV pressure catheter, the vena cava balloon, and
to afterload changes. However, at least cath lab animal
studies should be done to validate the noninvasive, oper-
ator independent, sensor builded FFR.
Positive vs. negative contractile reserve and medications
Medication differences may have had an impact, blunting
the force-frequency relation and the diastolic blood pres-
sure. However, this variable could not be controlled for
ethical and practical reasons. In addition, the index is rel-
atively independent of afterload changes, since for a given
level of contractility – blood pressure reduction should be
accompanied by smaller end-systolic volume values.
Conclusion
Force-frequency recording is feasible with single precor-
dial vibrations sensor connected to a standard ECG mon-
itoring electrode and quantitatively documents left
ventricular contractility changes in a totally automatic,
operator independent fashion.
Sensor built force-frequency relation is strictly related to
the standard stress echo built FFR. Echocardiography uses
artificially generated cardiac reflections. The isovolumic
systolic force sensor simply records naturally generated
heart vibrations. The FFR is built on line. The system is
portable, and the remote transmission of the FFR slope
and shape is feasible and simple.
To establish fully the advantages and limits of this new
method, comparisons with left ventricular pressure-vol-
ume loops in humans and multicenter study data are
needed.
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FFR = force-frequency relation
g = acceleration unit (9.8 m/sec2)
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SP = systolic pressure
SVR = systemic vascular resistance
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